Brand Name: Arcalion Generic Name: Sulbutiamine Indications: Symptomatic treatment of functional asthenia Drug Classification: Nootropics & Neurotonics Mechanism of Action: Sulbutamine increases physical resistance to fatigue, neuromuscular efficiency and learning and memory. It improves the metabolic functions of the cerebral cortex, it is d symptomatic treatment of functional asthenia. It is rapidly absorbed and the blood circulation is maimum in 1-2 hours after oral administration. Dosage: Adult: 23 tab daily Special Precautions: Use in pregnancy: No fetal toxicity or malformation has been reported. However, follow-up of women exposed to Arcalion during pregnancy is insufficient to exclude such a risk. Therefore, as a precautionary measure, it is preferable not to use Arcalion during pregnancy. Use in lactation: In the absence of data concerning the diffusion into breast milk, breastfeeding is not recommended during treatment. Pregnancy Risk Category: No fetal toxicity or malformation has been reported Adverse Reactions: Occasionally: Mild agitation in the elderly, allergic skin reactions
Contraindications: Hypersensitivity to the drug Form: Tab: 200 mg Nursing Responsibilities: Educate not to use during pregnancy (as much as possible) Not recommended during lactation Instruct patient to report any allergic reaction